InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Catriona Yale, Chief Development Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 46 open-market SEC Form 4 transactions: 0 purchases worth $0 and 46 sales worth $12.0M, reported from Aug 16, 21 to Sep 11, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 25 | AKROAkero Therapeutics, Inc. | SELL | 659 | $43.02 | $28K |
| Jul 16, 25 | AKROAkero Therapeutics, Inc. | SELL | 8.7K | $53.47 | $458K |
| Jun 18, 25 | AKROAkero Therapeutics, Inc. | SELL | 1.6K | $54.84 | $90K |
| Jun 16, 25 | AKROAkero Therapeutics, Inc. | SELL | 6.2K | $55.52 | $334K |
| Jun 10, 25 | AKROAkero Therapeutics, Inc. | SELL | 2.8K | $54.00 | $151K |
| May 15, 25 | AKROAkero Therapeutics, Inc. | SELL | 4.4K | $39.91 | $175K |
| Apr 15, 25 | AKROAkero Therapeutics, Inc. | SELL | 7.9K | $38.62 | $298K |
| Mar 17, 25 | AKROAkero Therapeutics, Inc. | SELL | 8.2K | $45.05 | $367K |
| Mar 12, 25 | AKROAkero Therapeutics, Inc. | SELL | 614 | $44.88 | $28K |
| Feb 18, 25 | AKROAkero Therapeutics, Inc. | SELL | 9.1K | $50.63 | $453K |
| Jan 27, 25 | AKROAkero Therapeutics, Inc. | SELL | 27.3K | $57.02 | $1.6M |
| Dec 16, 24 | AKROAkero Therapeutics, Inc. | SELL | 9.1K | $29.11 | $264K |
| Dec 10, 24 | AKROAkero Therapeutics, Inc. | SELL | 2.8K | $30.79 | $87K |
| Nov 15, 24 | AKROAkero Therapeutics, Inc. | SELL | 8.8K | $28.82 | $243K |
| Nov 6, 24 | AKROAkero Therapeutics, Inc. | SELL | 10.0K | $35.19 | $352K |
| Nov 1, 24 | AKROAkero Therapeutics, Inc. | SELL | 15.5K | $32.62 | $505K |
| Oct 30, 24 | AKROAkero Therapeutics, Inc. | SELL | 4.5K | $32.53 | $147K |
| Oct 15, 24 | AKROAkero Therapeutics, Inc. | SELL | 14.5K | $30.93 | $443K |
| Oct 14, 24 | AKROAkero Therapeutics, Inc. | SELL | 6.1K | $30.03 | $184K |
| Sep 20, 24 | AKROAkero Therapeutics, Inc. | SELL | 5.5K | $27.65 | $152K |
| Sep 18, 24 | AKROAkero Therapeutics, Inc. | SELL | 3.9K | $27.56 | $107K |
| Sep 17, 24 | AKROAkero Therapeutics, Inc. | SELL | 2.0K | $27.55 | $56K |
| Sep 16, 24 | AKROAkero Therapeutics, Inc. | SELL | 2.5K | $27.52 | $68K |
| Sep 10, 24 | AKROAkero Therapeutics, Inc. | SELL | 637 | $26.18 | $17K |
| Sep 3, 24 | AKROAkero Therapeutics, Inc. | SELL | 949 | $27.61 | $26K |
| Aug 26, 24 | AKROAkero Therapeutics, Inc. | SELL | 5.2K | $27.51 | $143K |
| Aug 23, 24 | AKROAkero Therapeutics, Inc. | SELL | 8.9K | $27.53 | $244K |
| Jun 11, 24 | AKROAkero Therapeutics, Inc. | SELL | 2.8K | $22.64 | $64K |
| Mar 13, 24 | AKROAkero Therapeutics, Inc. | SELL | 723 | $28.33 | $20K |
| Mar 4, 24 | AKROAkero Therapeutics, Inc. | SELL | 20.6K | $35.49 | $733K |
| Dec 14, 23 | AKROAkero Therapeutics, Inc. | SELL | 597 | $20.76 | $12K |
| Sep 21, 23 | AKROAkero Therapeutics, Inc. | SELL | 2.8K | $48.36 | $134K |
| Sep 13, 23 | AKROAkero Therapeutics, Inc. | SELL | 617 | $50.34 | $31K |
| Aug 28, 23 | AKROAkero Therapeutics, Inc. | SELL | 5.2K | $50.67 | $262K |
| Jun 23, 23 | AKROAkero Therapeutics, Inc. | SELL | 10.5K | $51.41 | $533K |
| Jun 22, 23 | AKROAkero Therapeutics, Inc. | SELL | 11.0K | $52.18 | $574K |
| Jun 21, 23 | AKROAkero Therapeutics, Inc. | SELL | 11.3K | $52.26 | $593K |
| Jun 13, 23 | AKROAkero Therapeutics, Inc. | SELL | 591 | $55.16 | $33K |
| Jan 13, 23 | AKROAkero Therapeutics, Inc. | SELL | 1.5K | $51.99 | $77K |
| Dec 12, 22 | AKROAkero Therapeutics, Inc. | SELL | 4.6K | $43.77 | $199K |
| Nov 10, 22 | AKROAkero Therapeutics, Inc. | SELL | 4.9K | $39.96 | $193K |
| Oct 10, 22 | AKROAkero Therapeutics, Inc. | SELL | 5.0K | $37.99 | $190K |
| Sep 13, 22 | AKROAkero Therapeutics, Inc. | SELL | 26.0K | $28.04 | $707K |
| Oct 15, 21 | AKROAkero Therapeutics, Inc. | SELL | 12.4K | $22.34 | $268K |
| Sep 15, 21 | AKROAkero Therapeutics, Inc. | SELL | 10.5K | $25.31 | $258K |
| Aug 16, 21 | AKROAkero Therapeutics, Inc. | SELL | 10.0K | $18.79 | $188K |